Neurotrophic and neuroprotective potential of human limbus-derived mesenchymal stromal cells |
| |
| Affiliation: | 1. Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan;2. Graduate Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei, Taiwan;3. Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan;4. Department of Neurosurgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan;5. Department of Pharmacy Practice, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan;6. Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan;7. Department of Nuclear Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan;1. Division of Plastic and Hand Surgery, University Hospital Zurich, Zurich, Switzerland;2. Department of Clinical Research, University of Bern, Bern, Switzerland;3. Center for Clinical Research, University of Zurich, Zurich, Switzerland;4. Department of Ophthalmology, University of Bern, Inselspital, Bern, Switzerland;1. Department of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China;2. Department of Neurology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu, China;3. Department of Rehabilitation Medicine, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu, China;4. Department of Interventional Radiology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu, China;5. Department of Plastic Surgery, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu, China;1. Oncohematology Research Group, Navarrabiomed, Miguel Servet Foundation, Pamplona, Spain;2. Department of Haematology, Complejo Hospitalario de Navarra, Navarra Health Service, Pamplona, Spain;3. Department of Haematology, University College London Medical School, University College London, London, United Kingdom;1. Department of Orthopedics, Korea University Ansan Hospital, Ansan, South Korea;2. Next-Generation Pharmaceutical Research Center, Korea Institute of Toxicology, Daejeon, Republic of Korea;3. Scoliosis Research Institute, Department of Orthopedics, Korea University Guro Hospital, Seoul, South Korea |
| |
| Abstract: | ![]()
Background aimsThe purpose of this study was to examine neurotrophic and neuroprotective effects of limbus stroma-derived mesenchymal stromal cells (L-MSCs) on cortical neurons in vitro and in vivo.MethodsCultured L-MSCs were characterized by flow cytometry and immunofluorescence through the use of specific MSC marker antibodies. Conditioned media were collected from normoxia- and hypoxia-treated L-MSCs to assess neurotrophic effects. Neuroprotective potentials were evaluated through the use of in vitro hypoxic cortical neuron culture and in vivo rat focal cerebral ischemia models. Neuronal morphology was confirmed by immunofluorescence with the use of anti-MAP2 antibody. Post-ischemic infarct volume and motor behavior were assayed by means of triphenyltetrazolium chloride staining and open-field testing, respectively. Human growth antibody arrays and enzyme-linked immunoassays were used to analyze trophic/growth factors contained in conditioned media.ResultsIsolated human L-MSCs highly expressed CD29, CD90 and CD105 but not CD34 and CD45. Mesenchymal lineage cell surface expression pattern and differentiation capacity were identical to MSCs derived form human bone marrow and adipose tissue. The L-MSC normoxic and hypoxic conditioned media both promoted neurite outgrowth in cultured cortical neurons. Hypoxic conditioned medium showed superior neurotrophic function and neuroprotective potential with reduced ischemic brain injury and improved functional recovery in rat focal cerebral ischemia models. Human growth factor arrays and enzyme-linked immunoassays measurements showed neuroprotective and growth-associated cytokines (vascular endothelial growth factor [VEGF], VEGFR3, brain-derived neurotrophic factor, insulin-like growth factor -2 and hepatocyte growth factor) contained in conditioned media. Hypoxic exposure caused VEGF and brain-derived neurotrophic factor upregulation, possibly contributing to neurotrophic and neuroprotective effects.ConclusionsL-MSCs can secrete various neurotrophic factors stimulating neurite outgrowth and protecting neurons against brain ischemic injury through paracrine mechanism. |
| |
| Keywords: | mesenchymal stromal cells neuroprotection paracrine |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
